Blue Horseshoe Stocks: PIHN, NGMC, MLCG

Polaris International Holdings, Inc. PIHN

We tagged PIHN in yesterday morning’s extended watchlist, with no idea that the stock would become the latest in a long line of companies that are jumping into the medical marijuana business.

Now, all of the sudden, a seemingly random stock that traded from .012-.0169 (+41%) yesterday, is now grabbing our attention for another reason.

If any of the other plays that we’ve seen take off on cannabis-related news are any indicator, the gain opportunities could continue to roll in. A predictable scenario could include the stock running off of this morning’s PR, pulling back as folks reap their profits, and following that with a subsequent bounce. A classic dip-and-rip would certainly not be out of the ordinary under these conditions, so we’ll want to continue to monitor PIHN as we cruise through mid-week.

PLANO, TX–(Marketwired – Mar 19, 2014) – Polaris International Holdings, Inc. (PINKSHEETS: PIHN) (OTC Pink: PIHN) is pleased to announce they have entered into an exclusive agreement with Longevity Holdings, LLC for the ProCannas® product line. The agreement grants the sole rights to sell, distribute and market the provisional patent-pending formulation of Longevity Holding, LLC cannabis oil. >>> FULL PR



Next Generation Energy Corp. NGMC

NMGC is another cannabis play with fresh news out today that we want to throw into the mix. The company has the intention to partner with an already-existing chain of marijuana dispensaries.

FAIRFAX, Va., March 19, 2014 /PRNewswire via COMTEX/ — Next Generation Energy Corp. (OTCQB:NGMC) announced today its major advancement into the Medical Marijuana industry. Darryl Reed, CEO of NGMC, said the Company’s wholly owned subsidiary, NextGen Cannabis Consulting LLC, has entered into a LOI with Highway 2 Health, Inc. (H2H). H2H currently owns and operates three dispensaries in the greater Los Angeles area and has extensive experience in the Medical Marijuana industry. >> FULL PR



ML Captial Group, Inc. MLCG

MLCG was another play from yesterday’s report to fare well off of some pot-related press, trading in a range from .0544-.074, an intraday move of 36%


Extended Watchlist:
AMZG, PLUG, WPCS, IDN, PSUN, IDRA, HTM, HZNP

BOSC, PSUN, ETAK, TGRO & Extended Watchlist

BOS Better Online Solutions Ltd. BOSC

Pacific Sunwear of California, Inc. PSUN

& Elephant Talk Communications, Inc. ETAK

Each of these three stocks traded up on unusually high volume on Friday after appearing in our Extended Watchlist, and wrapped up what was a very successful week of trading.

BOSC tapered back from opening above 9.00, and found its bottom at 7.9001. The stock then proceeded to rebound, bouncing back as high 8.80 for a nice 11% intraday gain on more than 10X the 3mo. average volume.

PSUN increased steadily all day on Friday, running from 2.92 to 3.44, good for a gain of 18% on roughly six times the 3mo. average volume.

ETAK saw a low of 1.01 on Friday, and enjoyed a respectable 17% gain to a high of 1.18, besting its average volume by more than 4X.


Tiger Oil & Energy, Inc. TGRO

We caught TGRO on a scan for plays with unusual activity, and thought we’d mention it this morning. This is a stock that was trading by appointment only for quite some time, that has sprung to life all of the sudden.

This comes shortly after a recent press release citing a proposed partnership with Toto Energy, LLC, wherein the two companies would undertake a joint venture of drilling up to three gas wells, in which TGRO would have a 30% interest. >>>More on the Joint Venture


Extended Watchlist:
RDCM, ADXS, UQM, HEB, ROSG, YRCW, GERN, BIEL (Coming off bottom with news)

PLUG, BLDP, MACK & Extended Watchlist

Plug Power, Inc. PLUG

We had a feeling that PLUG was going to continue its run yesterday, as stated in our daily report, and once again our instincts served us well. The momentum built up in this stock on Wednesday as it made a 23% move to close out the session on more than 6x the 3mo. average volume was impossible to ignore.

After opening at the key resistance point we outlined (1.45) PLUG briefly dipped to 1.43 and then barreled upward as it touched a high of 1.96, an intraday gain of 37% on roughly 14x the average volume. The momentum continued to build in PLUG and we continued to follow along closely. Remember, our coverage of this play goes back a long way, since the stock was trading in the .11-range.

This morning, the stock is gapping up above 2.00. The current pre-market high of 2.19 represents a gain of 1804% from the low following our first ever PLUG alert back on Feb 28th. The gain from our recent re-alert at a low of 1.04, at this morning’s high, stands at 111%

PLUG has certainly surpassed any expectations we had for it, and as you can see on the chart below, it appears currently overbought, which means the time to take profits off of the table is fast approaching. For newcomers, we believe the best action would be to patiently await a dip, and subsequent rebound, as has occurred several times this year.


Ballard Power Systems, Inc. BLDP

BLDP appeared on our extended watchlist on Wednesday, at which time the stock was trading at a low of 1.34. This morning, we are witnessing a gap-up on a PR that hit the wire post-market yesterday, with trades currently going off in the 1.80-range. We’ll want to keep an eye on the activity here as we close out the week, so we’re reserving a spot on our tickers for BLDP.

VANCOUVER, Dec. 5, 2013 /PRNewswire via COMTEX/ — Ballard Power Systems (NASDAQ: BLDP)(TSX: BLD) has announced the signing of a non-binding Memorandum of Understanding (MOU) with Van Hool NV, Europe’s fourth largest bus manufacturer, in support of the manufacture and further deployment of zero emission fuel cell buses.>>>FULL STORY


Merrimack Pharmaceuticals, Inc. MACK

MACK is another play we’ve been tracking recently, mentioning it for the first time on November 8th, when it was trading as low as 2.40. Like the previous play, MACK is gapping up this morning to the tune of more than 100% with shares changing hands for more than 4.80.

CAMBRIDGE, Mass., Dec. 6, 2013 (GLOBE NEWSWIRE) — Merrimack Pharmaceuticals, Inc. (MACK) today announced that Phase 1 data evaluating safety of the novel agent MM-302 in patients with advanced HER2-positive breast cancer will be presented at the 2013 San Antonio Breast Cancer Symposium (SABCS), December 10-14, 2013 in San Antonio, Texas.  >>> FULL STORY


Extended Watchlist:
GERN, BOSC, CPST, FCEL, PSUN, ENZN, ETAK, OCLS